Stockreport

Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial [Yahoo! Finance]

Lineage Cell Therapeutics, Inc.  (LCTX) 
PDF Lineage Cell Therapeutics, Inc. (NYSE:LCTX) is a clinical-stage biotech company developing allogeneic “off-the-shelf” cell therapies for neurological and ophthalmic dis [Read more]